Apimeds Pharmaceuticals US (APUS) Total Debt (2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Total Debt came in at $250000.0 in Q1 2025.
Apimeds Pharmaceuticals US (APUS) Total Debt (2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 1 years of Total Debt data on file, last reported at $250000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Apimeds Pharmaceuticals US | 7.20 Mn | 7.20 Mn | - | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 250,000.00 |